Rule change in HK to usher in wave of US IPOs

Changes allowing pre-revenue companies to list on the HKEx means that a number of biotech companies are likely to list on the exchange

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree